Intra-lesion injection of activated Natural Killer (NK) cells in recurrent malignant brain tumors.
Asl NS, Behfar M, Amiri RS, Mohseni R, Azimi M, Firouzi J, Faranoush M, Izadpanah A, Mohmmad M, Hamidieh AA, Habibi Z, Ebrahimi M.
Asl NS, et al. Among authors: mohseni r.
Int Immunopharmacol. 2023 Jul;120:110345. doi: 10.1016/j.intimp.2023.110345. Epub 2023 May 31.
Int Immunopharmacol. 2023.
PMID: 37267858